Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Perspective Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 39 | 43 | +4 |
| Shares | 15.9M | 16.8M | +844.1K (+5.3%) |
| Value | $5.79M | $5.19M | −$597.2K (−10.3%) |
New holders (8)
Institutions that held Perspective Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Venator Capital Management Ltd. | 550,000 | $170.0K | 0.29% |
| WCG Wealth Advisors LLC | 34,022 | $11.0K | 0.00% |
| Two Sigma Securities, LLC | 31,729 | $10.0K | 0.00% |
| Virtu Financial LLC | 24,471 | $8.00K | 0.00% |
| Great Valley Advisor Group, Inc. | 12,000 | $4.00K | 0.00% |
| Bank of America Corp | 1,000 | $0 | 0.00% |
| Chilton Capital Management LLC | 500 | $0 | 0.00% |
| Northwestern Mutual Wealth Management Co | 82 | $0 | 0.00% |
Sold out (4)
Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Bullseye Investment Management, LLC | 25,000 | $9.00K |
| Tower Research Capital LLC (TRC) | 13,795 | $5.00K |
| Douglass Winthrop Advisors, LLC | 10,000 | $4.00K |
| FNY Investment Advisers, LLC | 600 | $0 |